表紙:低侵襲胃腸外科システムの世界市場 (2021-2031年):12カ国の分析・予測
市場調査レポート
商品コード
991873

低侵襲胃腸外科システムの世界市場 (2021-2031年):12カ国の分析・予測

Global Minimally Invasive Gastrointestinal Surgical Systems Market: 12 Countries Analysis - Analysis and Forecast, 2021-2031

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 244 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=116.46円
低侵襲胃腸外科システムの世界市場 (2021-2031年):12カ国の分析・予測
出版日: 2021年03月02日
発行: BIS Research Inc.
ページ情報: 英文 244 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の低侵襲消化器外科システムの市場規模は予測期間中6.8%のCAGRで推移し、2020年の50億2180万米ドルから、2031年には104億4100万米ドルの規模に成長すると予測されています。

臨床上の意思決定における複雑さの増大、放射線科医の作業負荷の増大、大規模なR&D投資などの要因が同市場の成長を推進しています。専門家の不足、低侵襲消化器手術の高コスト性、償還上の制約などの課題が市場のさらなる成長の障壁となると予測されています。

当レポートでは、世界の低侵襲消化器外科システムの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、製品タイプ・手術区分・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

第4章 産業考察

  • 世界市場の概要
  • 産業構造
  • 産業のサプライチェーン
  • 法規制
  • 価格分析
  • COVID-19の影響

第5章 競合情勢

  • 主な展開・戦略
  • 市場シェア分析
  • 成長シェア分析

第6章 市場力学

  • 市場概要
  • 影響分析
  • 市場成長推進因子
  • 市場成長抑制因子
  • 市場機会

第7章 市場分析・予測:製品タイプ別

  • 従来型システム
    • 内視鏡・内視鏡システム
    • ビデオスコープ
    • 超音波内視鏡
    • 治療用エネルギーデバイス
  • 外科ロボティクス
    • ロボットシステム
    • ロボット手術器具・付属品
    • サービス

第8章 市場分析・予測:手術区分別

  • 副腎摘出術
  • 虫垂切除
  • 肥満手術
  • 胆嚢摘出術
  • 結腸・直腸手術
  • 前腸手術
  • ヘルニア修復

第9章 市場分析・予測:エンドユーザー別

  • 従来技術
    • 専門クリニック
    • 病院
    • 外来手術センター
  • 外科用ロボティクス
    • 病院
    • 外来手術センター
    • 専門クリニック

第10章 市場分析・予測:地域・主要国別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 定性分析

第12章 企業プロファイル

  • B. Braun Melsungen AG
  • Conmed Corporation
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Stryker Corporation
  • TransEnterix, Inc.
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Richard Wolf GmbH
  • Intuitive Surgical, Inc.
  • Ambu A/S
  • Scholly Fiber Optic GmbH
  • Xenocor, Inc.
  • Fujifilm Holdings Corporation
  • Pentax Medical (Hoya Corporation)
図表

List of Tables

  • Table 1: Impact of Market Drivers, 2021-2031
  • Table 2: Impact of Market Restraints, 2021-2031
  • Table 4.1: Minimally Invasive GI Surgical Systems: FDA Product Classification
  • Table 4.2: Average Selling Price for Different Types of Endoscopes (in $)
  • Table 4.3: Average Selling Price for Different Types of Visualization Systems (in $)
  • Table 6.1: Impact of Market Drivers, 2021-2031
  • Table 6.2: Impact of Market Restraints, 2021-2031
  • Table 6.3: Few Technological Advancements in the Field of GI Surgery
  • Table 7.1. Commercially Available Endoscope Products
  • Table 7.2: Commercially Available Endoscope Products
  • Table 12.1: TransEnterix, Inc.: Net Revenue (U.S. and International Market) ($Million), 2017-2019

List of Figures

  • Figure 1: Evolution of Surgery
  • Figure 2: Global Minimally Invasive Gastrointestinal Surgical Systems Market Size and Forecast, $Million, 2020-2031
  • Figure 3: Share of Key Developments and Strategies (by Category), January 2016-January 2021
  • Figure 4: Global Minimally Invasive GI Surgical Systems Market Share (by Surgery Type), 2020 and 2031
  • Figure 5: Global Minimally Invasive Gastrointestinal Surgical Systems Market Share (by End User), 2020 and 2031
  • Figure 6: Growth Share Analysis (by Region), 2021-2031
  • Figure 1.1: Comparative Analysis: Incision Length for Various Types of Surgery
  • Figure 2.1: Global Minimally Invasive Gastrointestinal Surgical Systems Market Segmentation
  • Figure 2.2: Regional Minimally Invasive Gastrointestinal Surgical Systems Market Segmentation
  • Figure 3.1: Global Minimally Invasive Gastrointestinal Surgical Systems Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Assumptions and Limitations
  • Figure 4.1: Global Minimally Invasive GI Surgical Systems Market Supply Chain Analysis
  • Figure 4.2: Regulatory Process for Medical Devices in the U.S.
  • Figure 4.3: MDR Transitional Provisions (EU)
  • Figure 4.4: Timeline and Impact of MDR (EU)
  • Figure 4.5: Regulatory Process for Medical Devices in European Union
  • Figure 4.6: Regulatory Process for Medical Devices in China
  • Figure 4.7: Regulatory Process for Medical Devices in Japan
  • Figure 5.1: Share of Key Developments and Strategies (by Category), January 2016-January 2021
  • Figure 5.2: Number of Key Developments and Strategies (by Year), January 2016-January 2021
  • Figure 5.3: Number of Key Developments and Strategies (Regulatory and Legal Activities), January 2016-January 2021
  • Figure 5.4: Number of Key Developments and Strategies (New Offerings), January 2016-January 2021
  • Figure 5.5: Number of Key Developments and Strategies (Partnerships, Alliances, and Business Expansions), January 2016-January 2021
  • Figure 5.6: Minimally Invasive Conventional Endoscopes Manufacturers Market Share (by Company)
  • Figure 5.7: Minimally Invasive Capsule Endoscopes Manufacturers Market Share (by Company)
  • Figure 5.8: Surgical Robotic Systems Manufacturers Market Share (by Company)
  • Figure 5.9: Growth Share Analysis (by Product Type), 2021-2031
  • Figure 5.10: Growth Share Analysis (by Surgery), 2021-2031
  • Figure 5.11: Growth Share Analysis (by End User), 2021-2031
  • Figure 5.12: Growth Share Analysis (by Region), $Million, 2021-2031
  • Figure 6.1: Market Dynamics
  • Figure 6.2: Advantages of Minimally Invasive Surgical Procedures
  • Figure 6.3: Healthcare Expenditure (by Country), All Financing Schemes, 2019
  • Figure 6.4: Factors Contributing to Adverse Events in Robotic-Assisted Surgical Procedures
  • Figure 6.5: Overview of Telesurgery Workflow
  • Figure 6.6: Telesurgery: Bridging the Gap Associated with Healthcare Accessibility
  • Figure 6.7: Inbound Medical Tourism Spending, 2017
  • Figure 7.1: Global Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type)
  • Figure 7.2: Global Minimally Invasive Gastrointestinal Surgical Systems Market Size and Forecast, $Million,2020-2031
  • Figure 7.3: Global Minimally Invasive Gastrointestinal Surgical Systems Market Share (by Product Type), 2020 and 2031
  • Figure 7.4: Global Minimally Invasive Gastrointestinal Surgical Systems Market Share (by Conventional MISS), 2020 and 2031
  • Figure 7.5: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (by Endoscopes and Endoscopy Systems)
  • Figure 7.6: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Share (by Endoscopes and Endoscopy System), 2020 and 2031
  • Figure 7.7: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Endoscopes and Endoscopy Systems), $Million, 2020-2031
  • Figure 7.8: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Rigid Endoscopes), $Million, 2020-2031
  • Figure 7.9: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Flexible Endoscopes), $Million, 2020-2031
  • Figure 7.10: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (by Capsule Endoscopy)
  • Figure 7.11: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Capsule Endoscopy), $Million, 2020-2031
  • Figure 7.12: Global Conventional Gastrointestinal Surgical Systems Market Share (by Capsule Endoscopy), 2020 and 2031
  • Figure 7.13: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Workstations and Data Recorders), $Million, 2020-2031
  • Figure 7.14: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Capsules), $Million, 2020-2031
  • Figure 7.15: Global Conventional Gastrointestinal Surgical Systems Market (Services and Patency System), $Million, 2020-2031
  • Figure 7.16: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Videoscopes), $Million, 2020-2031
  • Figure 7.17: Global Conventional Gastrointestinal Surgical Systems Market (Endoscopic Ultrasound), 2020-2031
  • Figure 7.18: Global Conventional Gastrointestinal Surgical Systems Market (Therapeutic Energy Devices), $Million, 2020-2031
  • Figure 7.19: Global Minimally Invasive Gastrointestinal Surgical Systems Market (by Surgical Robotics)
  • Figure 7.20: Global Minimally Invasive Gastrointestinal Surgical Systems Market Share (by Surgical Robotics), $Million, 2020 and 2031
  • Figure 7.21: Global Surgical Robotics Market (Robotic Systems), $Million, 2020-2031
  • Figure 7.22: Global Surgical Robotics Market (Robotic Surgery Instruments and Accessories), $Million, 2020-2031
  • Figure 7.23: Global Surgical Robotics Market (Services), $Million, 2020-2031
  • Figure 8.1: Global Minimally Invasive GI Surgical Systems Market (by Surgery)
  • Figure 8.2: Global Minimally Invasive GI Surgical Systems Market (by Surgery), $Million, 2020 and 2031
  • Figure 8.3: Global Minimally Invasive GI Surgical Systems Market (Adrenalectomy), $Million, 2020-2031
  • Figure 8.4: Global Minimally Invasive GI Surgical Systems Market (Appendectomy), $Million, 2020-2031
  • Figure 8.5: Global Minimally Invasive GI Surgical Systems Market (Bariatric Surgery), $Million, 2020-2031
  • Figure 8.6: Global Minimally Invasive GI Surgical Systems Market (Cholecystectomy), $Million, 2020-2031
  • Figure 8.7: Global Minimally Invasive GI Surgical Systems Market (Invasive Colon and Rectal Surgery), $Million, 2020-2031
  • Figure 8.8: Global Minimally Invasive GI Surgical Systems Market (Foregut Surgery), $Million, 2020-2031
  • Figure 8.9: Global Minimally Invasive GI Surgical Systems Market (Hernia Repair), $Million, 2020-2031
  • Figure 9.1: Global Minimally Invasive Gastrointestinal Surgical Systems Market (by End User)
  • Figure 9.2: Global Minimally Invasive Gastrointestinal Surgical Systems Market (Share by End User), $Million, 2020 and 2031
  • Figure 9.3: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Specialty Clinics), $Million, 2020-2031
  • Figure 9.4: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Hospitals), $Million, 2020-2031
  • Figure 9.5: Global Conventional Minimally Invasive Gastrointestinal Surgical Systems Market (Ambulatory Surgical Centers) $Million, 2020-2031
  • Figure 9.6: Global Surgical Robotics Minimally Invasive Gastrointestinal Surgical Systems Market (Hospitals), $Million, 2020-2031
  • Figure 9.7: Global Surgical Robotics Market (Ambulatory Surgical Centers), $Million, 2020-2031
  • Figure 9.8: Global Surgical Robotics Market (Specialty Clinics), $Million, 2020-2031
  • Figure 10.1: Global Minimally Invasive Gastrointestinal Surgical Systems Market (by Region), $Million, 2020 and 2031
  • Figure 10.2: North America Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.3: North America Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031 (by Product Type)
  • Figure 10.4: North America Minimally Invasive Gastrointestinal Surgical Systems Market (by Conventional System), $Million, 2020-2031
  • Figure 10.5: North America Minimally Invasive Gastrointestinal Surgical Systems (by Country), $Million, 2020 and 2031
  • Figure 10.6: U.S. Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.7: U.S. Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.8: Canada Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.9: Canada Minimally Invasive Surgical Gastrointestinal Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.10: Europe Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.11: Europe Minimally Invasive Gastrointestinal Surgical Systems Market, 2020-2031
  • Figure 10.12: Europe Minimally Invasive Gastrointestinal Surgical Systems Market (by Country), $Million, 2020 and 2031
  • Figure 10.13: Germany Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.14: Germany Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.15: France Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.16: France Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.17: Italy Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.18: Italy Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.19: U.K. Minimally Invasive Surgical Gastrointestinal Systems Market, $Million, 2020-2031
  • Figure 10.20: U.K. Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.21: Spain Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.22: Spain Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.23: Rest-of-Europe Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.24: Rest-of-Europe Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), 2020-2031
  • Figure 10.25: Asia-Pacific Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.26: Asia-Pacific Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.27: Asia-Pacific Minimally Invasive Gastrointestinal Surgical Systems Market (by Country), $Million, 2020 and 2031
  • Figure 10.28: Japan Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.29: Japan Minimally Invasive gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.30: China Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.31: China Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), 2020-2031
  • Figure 10.32: India Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.33: India Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.34: South Korea Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.35: South Korea Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.36: Australia and New Zealand Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.37: Australia and New Zealand Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.38: Rest-of-Asia-Pacific Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.39: Rest-of-Asia-Pacific Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 10.40: Rest-of-the-World Minimally Invasive Gastrointestinal Surgical Systems Market, $Million, 2020-2031
  • Figure 10.41: Rest-of-the-World Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), $Million, 2020-2031
  • Figure 11.1: Global Minimally Invasive GI Surgical Systems Market (by GI Tract)
  • Figure 12.1: Shares of Key Companies Profiled
  • Figure 12.2: B. Braun Melsungen AG: Overall Financials, $Million, 2017-2019
  • Figure 12.3: B. Braun Melsungen AG: Net Revenue (by Segment), 2017-2019
  • Figure 12.4: B. Braun Melsungen AG: Net Revenue (by Region), 2017-2019
  • Figure 12.5: Conmed Corporation: Overall Financials, $Million, 2017-2019
  • Figure 12.6: Conmed Corporation: Net Revenue (by Segment), $Million, 2017-2019
  • Figure 12.7: Conmed Corporation: Net Revenue (by Region), $Million, 2017-2019
  • Figure 12.8: Medtronic plc: Overall Financials, $Million, 2018-2020
  • Figure 12.9: Medtronic plc: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 12.10: Medtronic plc: Net Revenue (by Region), $Million, 2018-2020
  • Figure 12.11: Olympus Corporation: Overall Financials, $Million, 2018-2020
  • Figure 12.12: Olympus Corporation: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 12.13: Olympus Corporation: Net Revenue (by Region), $Million, 2018-2020
  • Figure 12.14: Stryker Corporation: Overall Financials, $Million, 2017-2019
  • Figure 12.15: Stryker Corporation: Net Revenue (by Segment), $Million, 2017-2019
  • Figure 12.16: Stryker Corporation: Net Revenue (by Region), $Million, 2017-2019
  • Figure 12.17: TransEnterix, Inc.: Overall Financials $Million, 2017-2019
  • Figure 12.18: TransEnterix, Inc.: Net Revenue (by Segment), $Million, 2017-2019
  • Figure 12.19: TransEnterix, Inc.: Net Revenue (by Region), $Million, 2017-2019
  • Figure 12.20: Boston Scientific Corporation: Overall Financials $Million, 2017-2019
  • Figure 12.21: Boston Scientific Corporation: Net Revenue (by Segment), $Million, 2017-2019
  • Figure 12.22: Boston Scientific Corporation: Net Revenue (by Region), $Million, 2017-2019
  • Figure 12.23: Intuitive Surgical, Inc.: Overall Financials $Million, 2017-2019
  • Figure 12.24: Intuitive Surgical, Inc.: Net Revenue (by Segment), $Million, 2017-2019
  • Figure 12.25: Intuitive Surgical, Inc.: Net Revenue (by Region), $Million, 2017-2019
  • Figure 12.26: Ambu A/S: Overall Financials $Million, 2018-2020
  • Figure 12.27: Ambu A/S: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 12.28: Ambu A/S: Net Revenue (by Region), $Million, 2018-2020
  • Figure 12.29: Fujifilm Holdings Corporation: Overall Financials $Million, 2018-2020
  • Figure 12.30: Fujifilm Holdings Corporation: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 12.31: Fujifilm Holdings Corporation: Net Revenue (by Region), $Million, 2018-2020
  • Figure 12.32: Hoya Corporation: Overall Financials, $Million, 2018-2020
  • Figure 12.33: Hoya Corporation: Net Revenue (by Segment), $Million, 2018-2020
  • Figure 12.34: Hoya Corporation: Net Revenue (by Region), $Million, 2020
目次
Product Code: BHR1024SA

"Global Minimally Invasive Gastrointestinal Surgical Systems Market to Reach $10.4 Billion by 2031."

Market Report Coverage - Minimally Invasive Gastrointestinal Surgical Systems

Market Segmentation

  • Product Type - Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)[Endoscopes and Endoscopy Systems, Videoscopes, Endoscopic Ultrasound, Therapeutic Energy Devices], Surgical Robotics (Robotic Systems, Robotic Surgery Instruments and Accessories, Services)
  • Surgery - Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, Hernia Repair
  • End User - Conventional Technologies (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Surgical Robotics (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)

Regional Segmentation

  • North America: U.S. and Canada
  • Europe: Germany, U.K, Italy, Spain, France, and Rest-of-Europe
  • Asia-Pacific: Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
  • Rest-of-the-World

Growth Drivers

  • Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures
  • Availability of Technological Advanced Products in the Field of GI Surgical Procedures
  • Increasing Healthcare Spending
  • Growth in Robotics GI Surgical Procedures

Market Challenges

  • High Cost of Minimally Invasive GI Surgical Procedures
  • Shortage of Skilled Professionals
  • Restrictive Reimbursement Framework

Market Opportunities

  • Development of Long-Distance Teleoperated Surgical Robotic Systems
  • Mergers and Acquisitions to Diversify Endoscopic Portfolio
  • Investment for Regional Expansionts

Key Companies Profiled

Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Scholly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc.

Key Questions Answered in this Report:

  • What is the current market size and future potential of these products?
  • What is the current market share and growth share of the different products in the market?
  • What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive gastrointestinal surgical systems?
  • What are the major market drivers, restraints, and opportunities in the global minimally invasive gastrointestinal surgical systems market?
  • What is the impact of the COVID-19 pandemic on the market?
  • Which technology is being researched and worked upon to improve the gastrointestinal surgical systems?
  • Who are the leading players dominating the global minimally invasive gastrointestinal surgical systems market?
  • What are the key development and strategies incorporated by the players of global minimally invasive gastrointestinal surgical systems market, to sustain the competition and retain their supremacy?
  • Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive gastrointestinal surgical systems market?
  • How advanced technologies such as surgical robotics is gaining traction in terms of market share in in gastrointestinal space?

Overview on the Global Minimally Invasive Gastrointestinal Surgical Systems Market

The global minimally invasive gastrointestinal surgical systems market is currently witnessing a significant change in the market landscape. There is rising investment in the development of healthcare infrastructure, increasing evidence for efficient and promising results in surgery assistance. Thus, this is leading to potential growth opportunities for the minimally invasive gastrointestinal surgical systems market. Moreover, there is an extensive entry of emerging players developing MIS surgical systems. All these predominant factors have led to a significant rise in sales of minimally invasive gastrointestinal surgical systems across the globe.

Global Minimally Invasive Gastrointestinal Surgical Systems Market (2020-2031)

The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031, growing at a CAGR of 6.8% during the forecast period 2021-2031. The increasing complexities in clinical decision-making, rising radiologist workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting the market growth. These challenges include the shortage of skilled professionals, high cost of minimally invasive GI surgical procedures, and restrictive reimbursement framework. Hence, it is anticipated that these trends will have a significant impact on the minimally invasive gastrointestinal surgical systems market in the during the forecast period, and the market will grow multifold.

Competitive Landscape

The global minimally invasive gastrointestinal surgical systems market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of technologies in healthcare, the manufacturers in the market have an ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

From January 2015 to January 2021, the market witnessed approximately 25 regulatory and legal developments, 11 new offerings, 44 partnerships, alliances, and business expansions, four funding activities, and seven mergers and acquisitions activities. Joint ventures, collaborations, and partnerships were among the most frequently followed strategies incorporated by numerous players to establish a strong foothold in the market.

Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel minimally invasive gastrointestinal surgical systems and attain a strong financial position in the market.

The leading imaging modality providers in the global minimally invasive gastrointestinal surgical systems market include Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Scholly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc., among others.

Table of Contents

Executive Summary

1 Product Definition

2 Scope of Research

  • 2.1 Research Scope
  • 2.2 Key Questions Answered in the Report
  • 2.3 Forecast Period Selection Criteria

3 Research Methodology

  • 3.1 Primary Research
  • 3.2 Secondary Research
  • 3.3 Data Sources Categorization
  • 3.4 Companies Profiled in the Report
  • 3.5 Market Estimation and Forecast Methodology
  • 3.6 Data Validation
  • 3.7 Assumptions and Limitations

4 Industry Insights

  • 4.1 Global Minimally Invasive Gastrointestinal Surgical Systems Market Overview
  • 4.2 Industry Structure
    • 4.2.1 Key Players
      • 4.2.1.1 Conventional Technologies Manufacturers
      • 4.2.1.2 Surgical Robotic Systems Manufacturers
      • 4.2.1.3 Emerging Players
    • 4.2.2 Regional Players
      • 4.2.2.1 North America
      • 4.2.2.2 Europe
      • 4.2.2.3 Asia-Pacific (APAC)
      • 4.2.2.4 Rest-of-the-World
  • 4.3 Industry Supply Chain Analysis
  • 4.4 Legal Regulations
    • 4.4.1 U.S.
    • 4.4.2 European Union (EU)
    • 4.4.3 China
    • 4.4.4 Japan
  • 4.5 Pricing Analysis
    • 4.5.1 Colonoscopy vs. Capsule Endoscopy
    • 4.5.2 Average Selling Price for Different Types of Endoscopes
  • 4.6 Impact of COVID-19

5 Competitive Landscape

  • 5.1 Key Developments and Strategies
    • 5.1.1 Regulatory and Legal
    • 5.1.2 New Offerings
    • 5.1.3 Partnerships, Alliances, and Business Expansions
    • 5.1.4 Mergers and Acquisitions
    • 5.1.5 Funding Activities
  • 5.2 Market Share Analysis
    • 5.2.1 Overview
    • 5.2.2 Conventional Technologies
      • 5.2.2.1 Conventional Endoscopy
      • 5.2.2.2 Capsule Endoscopy
    • 5.2.3 Surgical Robotics
  • 5.3 Growth Share Analysis
    • 5.3.1 Product Type
    • 5.3.2 Surgery Type
    • 5.3.3 End User
    • 5.3.4 Region

6 Market Dynamics

  • 6.1 Market Overview
  • 6.2 Impact Analysis
  • 6.3 Market Drivers
    • 6.3.1 Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures
    • 6.3.2 Availability of Technological Advanced Products in the Field of GI Surgical Procedures
    • 6.3.3 Increasing Healthcare Spending
    • 6.3.4 Growth in Robotics GI Surgical Procedures
  • 6.4 Market Restraints
    • 6.4.1 High Cost of Minimally Invasive GI Surgical Procedures
    • 6.4.2 Shortage of Skilled Professionals
    • 6.4.3 Restrictive Reimbursement Framework
  • 6.5 Market Opportunities
    • 6.5.1 Development of Long-Distance Teleoperated Surgical Robotic Systems
    • 6.5.2 Engagement in Mergers and Acquisitions to Diversify Endoscopic Portfolio
    • 6.5.3 Invest in Regional Expansion
    • 6.5.4 Development of Autonomous Surgical Robotic Systems

7 Global Minimally Invasive Gastrointestinal Surgical Systems Market (by Product Type), 2021-2031

  • 7.1 Overview
  • 7.2 Global Minimally Invasive Gastrointestinal Surgical Systems Market Scenario
  • 7.3 Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)
    • 7.3.1 Endoscopes and Endoscopy Systems
      • 7.3.1.1 Rigid Endoscopes
      • 7.3.1.2 Flexible Endoscopes
      • 7.3.1.3 Capsule Endoscopy
        • 7.3.1.3.1 Workstations and Data Recorders
        • 7.3.1.3.2 Capsules
        • 7.3.1.3.3 Others (Services and Patency System)
    • 7.3.2 Videoscopes
    • 7.3.3 Endoscopic Ultrasound
    • 7.3.4 Therapeutic Energy Devices
  • 7.4 Surgical Robotics
    • 7.4.1 Robotic Systems
    • 7.4.2 Robotic Surgery Instruments and Accessories
    • 7.4.3 Services

8 Global Minimally Invasive Gastrointestinal Surgical Systems Market (by Surgery)

  • 8.1 Market Overview
  • 8.2 Global Minimally Invasive GI Surgical Systems Market (by Surgery), $Million, 2020-2031
    • 8.2.1 Adrenalectomy
    • 8.2.2 Appendectomy
    • 8.2.3 Bariatric Surgery
    • 8.2.4 Cholecystectomy
    • 8.2.5 Colon and Rectal Surgery
    • 8.2.6 Foregut Surgery
    • 8.2.7 Hernia Repair

9 Global Minimally Invasive Gastrointestinal Surgical Systems Market (by End User)

  • 9.1 Market Overview
  • 9.2 Conventional Technologies (by End User), 2020-2031
    • 9.2.1 Specialty Clinics
    • 9.2.2 Hospitals
    • 9.2.3 Ambulatory Surgical Centers
  • 9.3 Surgical Robotics (by End User), 2020-2031
    • 9.3.1 Hospitals
    • 9.3.2 Ambulatory Surgical Centers
    • 9.3.3 Specialty Clinics

10 Global Minimally Invasive Gastrointestinal Surgical Systems Market (by Region)

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 Market Size and Forecast
    • 10.2.2 Key Vendors
    • 10.2.3 U.S.
      • 10.2.3.1 U.S. Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.2.4 Canada
      • 10.2.4.1 Canada Minimally Invasive Gastrointestinal Surgical Analysis (by Product Type)
  • 10.3 Europe
    • 10.3.1 Overview
    • 10.3.2 Market Size and Forecast
    • 10.3.3 Key Vendors
    • 10.3.4 Germany
      • 10.3.4.1 Germany Minimally Invasive Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.3.5 France
      • 10.3.5.1 France Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.3.6 Italy
      • 10.3.6.1 Italy Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.3.7 U.K.
      • 10.3.7.1 U.K. Minimally Invasive Gastrointestinal Surgical Analysis (by Product Type)
    • 10.3.8 Spain
      • 10.3.8.1 Spain Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.3.9 Rest-of-Europe
      • 10.3.9.1 Rest-of-Europe Minimally Invasive Gastrointestinal Surgical Analysis (by Product Type)
  • 10.4 Asia-Pacific
    • 10.4.1 Overview
    • 10.4.2 Market Size and Forecast
    • 10.4.3 Key Vendors
    • 10.4.4 Japan
      • 10.4.4.1 Japan Minimally Invasive gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.4.5 China
      • 10.4.5.1 China Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.4.6 India
      • 10.4.6.1 India Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.4.7 South Korea
      • 10.4.7.1 South Korea Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.4.8 Australia and New Zealand
      • 10.4.8.1 Australia and New Zealand Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
    • 10.4.9 Rest-of-Asia-Pacific
      • 10.4.9.1 Rest-of-Asia-Pacific Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)
  • 10.5 Rest-of-the-World
    • 10.5.1 Overview
    • 10.5.2 Market Size and Forecast
      • 10.5.2.1 Rest-of-the-World Minimally Invasive Gastrointestinal Surgical Systems Analysis (by Product Type)

11 Global Minimally Invasive Gastrointestinal Surgical Systems Market (by GI Tract) (Qualitative)

  • 11.1 Market Overview
  • 11.2 Global Minimally Invasive GI Surgical Systems Market (by Organ)
    • 11.2.1 Upper GI Tract
      • 11.2.1.1 Gastroscope
      • 11.2.1.2 Duodenoscope
    • 11.2.2 Lower GI Tract
      • 11.2.2.1 Enteroscope
      • 11.2.2.2 Colonoscope
      • 11.2.2.3 Sigmoidoscope
      • 11.2.2.4 Anoscope
      • 11.2.2.5 Rectoscope/Proctoscope
    • 11.2.3 Others
      • 11.2.3.1 Laparoscope
      • 11.2.3.2 Capsule Endoscope

12 Company Profiles

  • 12.1 Overview
  • 12.2 B. Braun Melsungen AG
    • 12.2.1 Company Overview
    • 12.2.2 Role of the Company
    • 12.2.3 Financials
    • 12.2.4 SWOT Analysis
  • 12.3 Conmed Corporation
    • 12.3.1 Company Overview
    • 12.3.2 Role of the Company
    • 12.3.3 Financials
    • 12.3.4 SWOT Analysis
  • 12.4 Karl Storz SE & Co. KG
    • 12.4.1 Company Overview
    • 12.4.2 Role of the Company
    • 12.4.3 SWOT Analysis
  • 12.5 Medtronic plc
    • 12.5.1 Company Overview
    • 12.5.2 Role of the Company
    • 12.5.3 Financials
    • 12.5.4 SWOT Analysis
  • 12.6 Olympus Corporation
    • 12.6.1 Company Overview
    • 12.6.2 Role of the Company
    • 12.6.3 Financials
    • 12.6.4 SWOT Analysis
  • 12.7 Stryker Corporation
    • 12.7.1 Company Overview
    • 12.7.2 Role of the Company
    • 12.7.3 Financials
    • 12.7.4 SWOT Analysis
  • 12.8 TransEnterix, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Role of the Company
    • 12.8.3 Financials
    • 12.8.4 SWOT Analysis
  • 12.9 Boston Scientific Corporation
    • 12.9.1 Company Overview
    • 12.9.2 Role of the Company
    • 12.9.3 Financials
    • 12.9.4 SWOT Analysis
  • 12.1 Cook Medical, Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Role of the Company
    • 12.10.3 SWOT Analysis
  • 12.11 Richard Wolf GmbH
    • 12.11.1 Company Overview
    • 12.11.2 Role of the Company
    • 12.11.3 SWOT Analysis
  • 12.12 Intuitive Surgical, Inc.
    • 12.12.1 Company Overview
    • 12.12.2 Role of the Company
    • 12.12.3 Financials
    • 12.12.4 SWOT Analysis
  • 12.13 Ambu A/S
    • 12.13.1 Company Overview
    • 12.13.2 Role of the Company
    • 12.13.3 Financials
    • 12.13.4 SWOT Analysis
  • 12.14 Scholly Fiber Optic GmbH
    • 12.14.1 Company Overview
    • 12.14.2 Role of the Company
    • 12.14.3 SWOT Analysis
  • 12.15 Xenocor, Inc.
    • 12.15.1 Company Overview
    • 12.15.2 Role of the Company
    • 12.15.3 SWOT Analysis
  • 12.16 Fujifilm Holdings Corporation
    • 12.16.1 Company Overview
    • 12.16.2 Role of the Company
    • 12.16.3 Financials
    • 12.16.4 SWOT Analysis
  • 12.17 Pentax Medical (Hoya Corporation)
    • 12.17.1 Company Overview
    • 12.17.2 Role of the Company
    • 12.17.3 Financials
    • 12.17.4 SWOT Analysis